Navigation Links
Nobel Honors 3 Former March of Dimes Prize Recipients
Date:10/9/2007

WHITE PLAINS, N.Y., Oct. 9 /PRNewswire-USNewswire/ -- The March of Dimes congratulates Mario R. Capecchi, Ph.D., Sir Martin J. Evans, Ph.D., DSc., FRS, and Oliver Smithies, D.Phil., FRS, former recipients of the March of Dimes Prize in Developmental Biology, on sharing this year's Nobel Prize in Physiology or Medicine.

The Nobel Committee announced yesterday that the three have been honored "for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells." The three scientists are pioneers in gene targeting, which allows researchers to address the most complex and critical biological problems, including the causes and treatment of birth defects and many other disorders, such as cancer, diabetes, and atherosclerosis.

"Before gene targeting, researchers could not pinpoint how a specific gene worked, and that was very frustrating," said Dr. Jennifer L. Howse, president of the March of Dimes. "Dr. Capecchi, Sir Martin, and Dr. Smithies, working independently, made a technological breakthrough that completely revolutionized biomedical research and our ability to study human disease and development. We're reaping the benefits every day with advances in genetic medicine."

Dr. Capecchi, Distinguished Professor and Co-Chairman of the Department of Human Genetics, University of Utah School of Medicine, and Dr. Smithies, Excellence Professor of Pathology and Laboratory Medicine at the University of North Carolina, Chapel Hill, shared the 2005 March of Dimes Prize in Developmental Biology. Sir Martin, former Director of the School of Biosciences and Professor of Mammalian Genetics of Cardiff University, was a co-recipient of the 1999 March of Dimes Prize.

The March of Dimes Prize in Developmental Biology has been awarded annually since 1996 to investigators whose research has profoundly advanced the science that underlies the understanding of birth defects.

Today's announcement bring
'/>"/>

SOURCE March of Dimes
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Stem cell research- now Nobel Laureates join the debate
3. Nobel laureates in chemistry
4. Nobel Prize for Medicine
5. Cholesterol Mystery Solved By Nobel Laureates
6. Nobel For Ulcer-Defying Aussie Scientists
7. Aussie Nobel Prize Winners Receive Their Awards
8. Nobel Laureate Finds an Alternate Way to Manufacture Anti-Flu Drug
9. Dutch chemical group Akzo Nobel Develops A New Bird Flu Vaccine
10. Two Americans Share 2006 Nobel Medicine Prize
11. Nobel Prize – a ‘near miss’ for Indian Scientist coule

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...K,Nov.25/PRNewswire/--Reportlinker.comannouncestha...: ,, TheMarketforAnti-ageingFoods(2ndEdition)...-Market-for-Anti-ageing-Foods-(2nd-Edition ).html ...elopatafastpacewithgrowthoutstrippingthatofconvent...andHealthClaimsDirective,sstrictapproachtohealthcl...
(Date:11/25/2009)...IFFLAKE,N.J.,Nov.25/PRNewswire-FirstCall/--ParPhar...theresultsofits"ModifiedDutchAuction"tenderoffer,i...aggregateprincipalamount,oruptoapproximately82.7%,...eNotesdue2010. ,, BasedonthecountbyAmericanStoc...tenderoffer,$30,805,000aggregateprincipalamountoft...
(Date:11/25/2009)...mily members can panic, underestimate effects of ...lthDay News) -- Thanksgiving is a time of eating t...ng your elderly loved one to the emergency room. ,... why: When family members who have not seen each o...hey are often alarmed by the health of their older...
(Date:11/25/2009)... Beginning Today through Sunday, Novemb...very memory foam and latex sofa bed mattress + an ...ing and a 100 night money back guarantee. Use the ...t to take advantage of this special offer. , ...illions of Americans will travel from Thanksgiving...
(Date:11/25/2009)... The American Society of Hematology (AS...lishing, education, and media company, are launchi...ynamic science curriculum designed to spark intere...ion to exposing students to exciting career opport...Washington (PRWEB) November 25, 2009 -- The Americ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 3Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 4Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 5Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 6Health News:Par Pharmaceutical Announces Results of Its 'Modified Dutch Auction' Tender Offer 2Health News:ER Visits for Elderly Rise During Thanksgiving 2Health News:ER Visits for Elderly Rise During Thanksgiving 3Health News:Providing Comfort for Holiday Guests Just Got Easier 2Health News:Providing Comfort for Holiday Guests Just Got Easier 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3
...diac Science Corporation (Nasdaq: CSCX ), a glob...ED ) and diagnostic monitoring devices ( ECG , ... rehabilitation ) that connect to EMR and HIS...cheduled a conference call with analysts and inves...
... Income , , POWAY, Calif., April 30 Digirad Corp...head of internal schedules on its 2009 goal of gen... flow. Net income was $44,000 for the first quart...uarter. We previously communicated our 2009 goals...
...thcare training organization has revamped its webs...nced navigation tools, to provide family and profe...resources and training options. , ...family and professional care providers find educat...
...Travel Insurance and Student Funding Group team up...y; Tuition Fee protection programs also added for ...(PRWEB) April 30, 2009 -- With a rise in interest ...unding Group (StuFund) to offer newly created, ine...
...vox UV Air Sterilization Systems are designed to d...swine influenza (H1N1 virus). , ... Sanuvox Technologies has been receiving inquirie...ir Sterilization Systems are designed to destroy a...
...ervention can be modified to teach self-screening ... April 30 A brief intervention program - consisti...ne calls - boosted by tenfold the number of women ...lth Promotion . , , Funded by the National Cance...
Other Medicine News:Health News:Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 2Health News:Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 3Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 2Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 3Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 4Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 5Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 6Health News:Medifecta Healthcare Training Launches Website with Educational Resources and Online Training for Caregivers 2Health News:New G1G Student Medical Insurance and Student Fee Protection Now on StuFund Web Site 2Health News:New G1G Student Medical Insurance and Student Fee Protection Now on StuFund Web Site 3Health News:Sanuvox UV Air Sterilization Systems Ability to Destroy Airborne Type A Influenza including Swine Flu (H1N1) 2Health News:Sanuvox UV Air Sterilization Systems Ability to Destroy Airborne Type A Influenza including Swine Flu (H1N1) 3Health News:Women Ten Times More Likely To Do Breast Self-Exams Correctly With Intervention Program, Kaiser Permanente Study Finds 2Health News:Women Ten Times More Likely To Do Breast Self-Exams Correctly With Intervention Program, Kaiser Permanente Study Finds 3Health News:Women Ten Times More Likely To Do Breast Self-Exams Correctly With Intervention Program, Kaiser Permanente Study Finds 4
(Date:11/24/2009)...Newswire/--Inadditiontofamily,friendsandhealth,can...toherThanksgivinggratitudelist. ,, "Theyheardth...esaidofMonday,sverdictstotaling$103millionindamage...g12,000womennationwidewhohavesuedWyethandPfizerpha...nandPrempro.Wisneskiandtheothervictimsofhormonethe...
(Date:11/24/2009)...RNewswire/--SpartaSystems,Inc.,themakerofTrackWise...mpliancesolutions,todayannouncedthatSSLInternation...eparentcompanyforgloballyrecognizedbrandssuchasDur...ityManagementSystem(EQMS).Thecompanyisnowleveragin...operationsthatincludeCorrectiveandPreventiveAction...
(Date:11/24/2009)...Newswire-Asia/--HuifengBio-Pharmaceutical,Technolo...dproducer,ofplantextractsandpharmaceuticalrawmater...oductioninXi,an,China,todayreportedthatinits,third..., RevenuesforthequarterendedSept.30,2009were$...23forthesamequarterin2008.Netincome,amountedto1,00...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Improving schools for disabled students is NJIT researchers mission 59864 1Improving schools for disabled students is NJIT researchers mission 59864 2Improving schools for disabled students is NJIT researchers mission 59864 3Penn team uses self assembly to make molecule sized particles with patches of charge 10447 1Penn team uses self assembly to make molecule sized particles with patches of charge 10447 2Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 1Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 2Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 3Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 4Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 5Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 6
...SCO, Dec. 8 Millennium: The Takeda Oncology Compa...d follow up of patients from the large, internatio...vival improvement for patients with previously unt...nd prednisone (VcMP). The VELCADE combination demo...oups, including those with poor prognostic charact...
...SCO, Dec. 8 Millennium: The Takeda Oncology,Compa...multi-center,randomized Phase III clinical trials ...eatment of transplant-eligible patients with previ...rogression-free survival (PFS) was observed,in one...ith vincristine,adriamycin and dexamethasone (VAD)...
Other Medicine Technology:Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7
Kuglen Push-Pull Hook
Serdarevic Suture Hook
Sinskey Hook II
Lewicky Hook
Medicine Products: